Sugi Predict

Sugi Predict / Compounds / SCHEMBL24072

SCHEMBL24072

SCHEMBL24072

CC(C)CCc1cc[c]cc1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ AOC3 Q16853 2/20 0.34
▸ TSHR P16473 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ PKM P14618 1/20 0.32
▸ HTT P42858 2/20 0.32
▸ SMN1; SMN2 Q16637 2/20 0.32
▸ DHODH Q02127 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ OPRM1 P35372 1/20 0.31
▸ OPRD1 P41143 1/20 0.31
▸ OPRK1 P41145 1/20 0.31
▸ ALDH1A1 P00352 1/20 0.31
▸ CYP1A2 P05177 1/20 0.31
▸ CYP2C9 P11712 1/20 0.31
▸ CYP2C19 P33261 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28529484 0.98 AOC3 (0.33) AOC3TSHRLMNAPKMHTT
SCHEMBL814842 0.86 GRIN2D (0.40) AOC3LMNAPKMHTTSMN1; SMN2
SCHEMBL814782 0.85 FUT7 (0.38) LMNAPKMALDH1A1KMT2AHPGD
SCHEMBL348349 0.84 LMNA (0.46) LMNAPKMHTTALDH1A1MEN1
SCHEMBL941936 0.83 FUT7 (0.41) LMNAPKMALDH1A1
SCHEMBL1455235 0.83 FUT7 (0.41) LMNAPKMALDH1A1
SCHEMBL11116545 0.83 FUT7 (0.41) LMNAPKMALDH1A1
SCHEMBL5204239 0.83 FUT7 (0.41) LMNAPKMALDH1A1
SCHEMBL941931 0.83 FUT7 (0.41) LMNAPKMALDH1A1
SCHEMBL1569826 0.82 SLC6A2 (0.46) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1049 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117897149-A 3, 4-methylenedioxymethamphetamine and related hallucinogens and uses thereof 人类生物科学股份有限公司 2024-04-16 — — CN claimed
US-20230250200-A1 IMPROVED CATALYSTS FOR INTERMOLECULAR CYCLOADDITION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2023-08-10 — — US claimed
US-20220393118-A1 TETRADENTATE LIGANDS, GOLD(III) COMPLEXES, PREPARATION METHOD AND USE THEREOF CHE, CHI MING (CN) 2022-12-08 — — US claimed
CN-115304601-A Acridine-containing fused ring derivative and application thereof 北京鼎材科技有限公司 2022-11-08 — — CN claimed
EP-4017936-A1 TETRADENTATE LIGANDS, GOLD(III) COMPLEXES, PREPARATION METHOD AND USE THEREOF Che, Chi Ming (HK) 2022-06-29 — — EP claimed
WO-2021126692-A1 IRON BIS(IMINO) ARYL CATALYSTS AND METHODS THEREOF EXXONMOBIL CHEMICAL PATENTS INC. (US) 2021-06-24 — — WO claimed
US-20210179650-A1 Iron Bis(Imino) Aryl Catalysts and Methods Thereof EXXONMOBIL CHEMICAL PATENTS INC (US) 2021-06-17 — — US claimed
WO-2021036978-A1 TETRADENTATE LIGANDS, GOLD(III) COMPLEXES, PREPARATION METHOD AND USE THEREOF CHE CHI MING (CN) 2021-03-04 — — WO claimed
CN-112409243-A Tetradentate ligand, gold (III) complex, and preparation method and application thereof 支志明 2021-02-26 — — CN claimed
CN-106232120-B Process for preparing N-benzyl-3-hydroxy-4-substituted-pyridin-2- (1H) -ones 爱尔皮奥治疗有限公司 2021-01-08 — — CN claimed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 — — EP claimed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 — — US claimed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 — — EP claimed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 — — WO claimed
US-6649623-B1 Administering tetrahydropiperidine derivative; antidiabetic agents; hyperlipemia treatment; hypotensive agents SHIONOGI & CO., LTD. (JP) 2003-11-18 — — US claimed
CN-1346347-A Cyclic amine derivatives and their use SHIONOGI & CO (JP) 2002-04-24 — — CN claimed
EP-1151993-A1 CYCLIC AMINE DERIVATIVES AND USES THEREOF SHIONOGI & CO., LTD. (JP) 2001-11-07 — — EP claimed
EP-0362649-B1 Radiation-sensitive compositions and their use BASF AG (DE) 1994-03-02 — — EP claimed
EP-0362644-B1 RADIATION-SENSITIVE COMPOSITIONS AND THEIR USE BASF Aktiengesellschaft (DE) 1993-05-26 — — EP claimed
US-4195042-A Rhodium hydroformylation catalyst PHILLIPS PETROLEUM COMPANY (US) 1980-03-25 — — US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210179650-A1 Iron Bis(Imino) Aryl Catalysts and Methods Thereof IDO2, SLC40A1, IDO1 AOC3 148/4885TSHR 4059/4885LMNA 3566/4885
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 AOC3 153/4885TSHR 4680/4885LMNA 178/4885
US-20220393118-A1 TETRADENTATE LIGANDS, GOLD(III) COMPLEXES, PREPARATION METHOD AND USE THEREOF PDCD2L, TTL, TTLL12 AOC3 317/4885TSHR 296/4885LMNA 3175/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.